FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092768436> ?p ?o ?g. }

• W3092768436 endingPage "11" @default.
• W3092768436 startingPage "1" @default.
• W3092768436 abstract "The aim of this study was to evaluate the outcome of transcatheter mitral valve repair (TMVr) in patients with cardiogenic shock and significant mitral regurgitation (MR). Patients in cardiogenic shock with severe MR have a poor prognosis in the setting of conventional medical therapy. Because of its favorable safety profile, TMVr is being increasingly used as an acute therapy in this population, though its efficacy remains unknown. A multicenter, collaborative, patient-level analysis was conducted. Patients with cardiogenic shock and moderate to severe (3+) or severe (4+) MR who were not surgical candidates were treated with TMVr. The primary outcome was in-hospital mortality. Secondary outcomes included 90-day mortality, heart failure (HF) hospitalization, and the combined event rate of 90-day mortality and HF hospitalization following dichotomization by TMVr device success. Between January 2011 and February 2019, 141 patients across 14 institutions met the inclusion criteria. In-hospital mortality occurred in 22 patients (15.6%), at 90 days in 38 patients (29.5%), and at one year in 55 patients (42.6%). Median length of hospital stay following TMVr was 10 days (interquartile range: 6 to 20 days). HF hospitalization occurred in 26 patients (18.4%) at a median of 73 days (interquartile range: 26 to 546 days). When stratified by TMVr procedural results, successful TMVr reduced rates of in-hospital mortality (hazard ratio [HR]: 0.36; 95% confidence interval [CI]: 0.13 to 0.98; p = 0.04), 90-day mortality (HR: 0.36; 95% CI: 0.16 to 0.78; p = 0.01), and the composite of 90-day mortality and HF hospitalization (HR: 0.41; 95% CI: 0.19 to 0.90; p = 0.03). TMVr may improve short- and intermediate-term mortality in high-risk patients with cardiogenic shock and moderate to severe MR. Randomized studies are needed to definitively establish MR as a therapeutic target in patients with cardiogenic shock." @default.
• W3092768436 created "2020-10-22" @default.
• W3092768436 creator A5000141941 @default.
• W3092768436 creator A5001675402 @default.
• W3092768436 creator A5003972191 @default.
• W3092768436 creator A5010412902 @default.
• W3092768436 creator A5010450672 @default.
• W3092768436 creator A5011814572 @default.
• W3092768436 creator A5013991233 @default.
• W3092768436 creator A5013997692 @default.
• W3092768436 creator A5014087834 @default.
• W3092768436 creator A5015219128 @default.
• W3092768436 creator A5021978173 @default.
• W3092768436 creator A5023135025 @default.
• W3092768436 creator A5023479699 @default.
• W3092768436 creator A5026057493 @default.
• W3092768436 creator A5027777883 @default.
• W3092768436 creator A5029966654 @default.
• W3092768436 creator A5031144409 @default.
• W3092768436 creator A5032821643 @default.
• W3092768436 creator A5037471440 @default.
• W3092768436 creator A5037854769 @default.
• W3092768436 creator A5039963903 @default.
• W3092768436 creator A5043197177 @default.
• W3092768436 creator A5044743374 @default.
• W3092768436 creator A5053291734 @default.
• W3092768436 creator A5056892721 @default.
• W3092768436 creator A5058763168 @default.
• W3092768436 creator A5061636317 @default.
• W3092768436 creator A5063911245 @default.
• W3092768436 creator A5072261213 @default.
• W3092768436 creator A5072957878 @default.
• W3092768436 creator A5078231013 @default.
• W3092768436 creator A5079543223 @default.
• W3092768436 creator A5082355570 @default.
• W3092768436 creator A5083616613 @default.
• W3092768436 creator A5083906814 @default.
• W3092768436 creator A5088056147 @default.
• W3092768436 creator A5088090381 @default.
• W3092768436 creator A5090799220 @default.
• W3092768436 creator A5090814627 @default.
• W3092768436 date "2021-01-01" @default.
• W3092768436 modified "2023-10-16" @default.
• W3092768436 title "Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation" @default.
• W3092768436 cites W1605552999 @default.
• W3092768436 cites W1845635296 @default.
• W3092768436 cites W2026588012 @default.
• W3092768436 cites W2034185700 @default.
• W3092768436 cites W2073433346 @default.
• W3092768436 cites W2130007894 @default.
• W3092768436 cites W2149463609 @default.
• W3092768436 cites W2152351169 @default.
• W3092768436 cites W2540963844 @default.
• W3092768436 cites W2751630023 @default.
• W3092768436 cites W2766152280 @default.
• W3092768436 cites W2888290077 @default.
• W3092768436 cites W2889688444 @default.
• W3092768436 cites W2893726102 @default.
• W3092768436 cites W2914532763 @default.
• W3092768436 cites W2914956909 @default.
• W3092768436 cites W2925906209 @default.
• W3092768436 cites W2944445588 @default.
• W3092768436 cites W2945771063 @default.
• W3092768436 cites W2946676024 @default.
• W3092768436 cites W2965446700 @default.
• W3092768436 cites W2988642807 @default.
• W3092768436 cites W2995216299 @default.
• W3092768436 cites W3037368432 @default.
• W3092768436 cites W838389765 @default.
• W3092768436 doi "https://doi.org/10.1016/j.jcin.2020.08.037" @default.
• W3092768436 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33069653" @default.
• W3092768436 hasPublicationYear "2021" @default.
• W3092768436 type Work @default.
• W3092768436 sameAs 3092768436 @default.
• W3092768436 citedByCount "51" @default.
• W3092768436 countsByYear W30927684362021 @default.
• W3092768436 countsByYear W30927684362022 @default.
• W3092768436 countsByYear W30927684362023 @default.
• W3092768436 crossrefType "journal-article" @default.
• W3092768436 hasAuthorship W3092768436A5000141941 @default.
• W3092768436 hasAuthorship W3092768436A5001675402 @default.
• W3092768436 hasAuthorship W3092768436A5003972191 @default.
• W3092768436 hasAuthorship W3092768436A5010412902 @default.
• W3092768436 hasAuthorship W3092768436A5010450672 @default.
• W3092768436 hasAuthorship W3092768436A5011814572 @default.
• W3092768436 hasAuthorship W3092768436A5013991233 @default.
• W3092768436 hasAuthorship W3092768436A5013997692 @default.
• W3092768436 hasAuthorship W3092768436A5014087834 @default.
• W3092768436 hasAuthorship W3092768436A5015219128 @default.
• W3092768436 hasAuthorship W3092768436A5021978173 @default.
• W3092768436 hasAuthorship W3092768436A5023135025 @default.
• W3092768436 hasAuthorship W3092768436A5023479699 @default.
• W3092768436 hasAuthorship W3092768436A5026057493 @default.
• W3092768436 hasAuthorship W3092768436A5027777883 @default.
• W3092768436 hasAuthorship W3092768436A5029966654 @default.
• W3092768436 hasAuthorship W3092768436A5031144409 @default.
• W3092768436 hasAuthorship W3092768436A5032821643 @default.
• W3092768436 hasAuthorship W3092768436A5037471440 @default.

• next